Navigation Links
ProStar XL 10 Suture-Mediated Closure

ProductsProStar XL 10 Suture-Mediated Closure
Company Abbott Vascular
Item ProStar XL 10 Suture-Mediated Closure
Features Unique Design
  • Sheath has a hydrophilic coating to facilitate insertion
  • Standard .038 guide wire compatible
  • Four Nitinol needles deployed from below the arteriotomy
  • Two braided polyester sutures
Suture-Mediated Closure
  • Delivers secure reliable vessel closure
  • Designed to provide complete tissue apposition resulting in primary healing
  • Provides reduced time to hemostasis, ambulation and discharge
Description The Prostar XL 10F Percutaneous Vascular Surgical (PVS) System consists of the Prostar XL 10F PVS Device and a Perclose Knot Pusher. The Prostar XL 10F PVS Devices are composed of a sheath which contains two pairs of sutured needles as well as a needle guide and a rotating barrel which precisely control the needles during deployment. the Perclose Knot Pusher is used to advance surgical knots to the arteriotomy. The Perclose Arterial Tamper is an optional accessory if, in the judgment of the physician, additional hemostatic control of the site is required. Hemostasis is achieved by means of a percutaneous surgical closure of the arteriotomy following diagnostic or interventional catheterization procedures.

The Prostar XL 10F PVS Device is designed for use in 8.5F to 10F access sites.

The Prostar XL 10F PVS System is indicated for the percutaneous delivery of sutures for closing the common femoral artery access site, reducing the time to hemostasis and time to ambulation (patient walks ten feet) for patients who have undergone catheterization procedure using 8.5F to 10F sheaths.

Info Abbott Vascular
Customer Service: (800) 227-9902
Web site: http://www.abbottvascular.com/

Related medicine products :

1. ProStar XL 8 Suture-Mediated Closure
2. Perclose ProGlide Suture-Mediated Closure
3. Closer S Suture-Mediated Closure
4. Perclose A-T Suture-Mediated Closure
5. CARDIA Patent Foramen Ovale Closure Device
6. CARDIA Patent Ductus Arteriosus Closure Device
7. CARDIA Atrial Septal Defect Closure Device
8. Premere PFO Closure System
9. Endo Closetrade; Trocar Site Closure Device
10. Comfor™ Clavicle Brace - Buckle Closure
11. Front Closure Clavicle Support
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
Medicine Products:
(Date:12/16/2009)... Dec. 16 Medizone International, Inc. (OTC ... Board of Directors and the Board of Medizone ... Medizone International Inc. holds a 50% interest, agreed ... venture and reconvey to Medizone International all global ... Medizone International,s Chairman, Edwin G. Marshall said, "Time ...
(Date:12/16/2009)... Delaware, December 16 While many ... their accurate forecast models,for new and inmarket ... patient-based forecast solutions to various players. These ... phase II, as well as phase,III. These ... product life cycle,management, market entry strategy, manufacturing ...
(Date:12/16/2009)... access to patient information could improve care, but ... 16 (HealthDay News) -- U.S. physicians support the ... exist about privacy problems, two new studies show. ... practice and specialist doctors in Massachusetts found that ... would improve patient quality of care, 70 percent ...
(Date:12/16/2009)... in triathalons and appeared on The Amazing Race ... to think of herself as part human, part machine. , ... 34-year-old triathlete likes to describe herself. When she,s not training ... school auditoriums or posing nude with her metal leg crossed ... latest ESPN Body Issue. , She is the ...
(Date:12/16/2009)... site visitors can earn a free 21-count one week trial bottle ... ... Orion, MI (PRWEB) December 16, 2009 -- ImmuneResponse247.com ... Trial Sample” of Immune Response 247™ 6 Mushroom Formula , ... Medicinals, Immune Response 247™ 6 Mushroom Formula is packaged in FDA ...
Breaking Medicine News(10 mins):Health News:Medizone International, Inc. Approves Repurchase of Global Marketing Rights 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 2Health News:MarketsandMarket's Integrated Patient-based Forecasting Solution for Pharmaceutical Industry, Mainly for Pipeline Products 3Health News:Pros and Cons of Electronic Medical Records Weighed 2Health News:Amputee Athlete Tells Her Story 2Health News:Amputee Athlete Tells Her Story 3Health News:Amputee Athlete Tells Her Story 4Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 2Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 3Health News:Free Sample of Proven Health Mushroom Supplement Offered By ImmuneResponse247.com 4
... Internet - , , ANTHEM, Ariz., Dec. 29 ... of its new web site at http://www.mychoicedentist.com and ... Phoenix , Arizona, area is proceeding successfully. "Arizona is ... CEO. "We anticipate expanding this service to almost every major ...
... Now Worth Twenty-Five Thousand Dollars at www.MaxMuscle.com/max-formation/ , ... ... Sports Nutrition is rewarding $25,000 cash to the individual who can ... lean muscle and fitness in 2009., , , , ,Bring Yourself ...
... Critically ill patients frequently have uncertain prognoses, but ... prognostic uncertainty candidly, according to a new study ... Center. , "Our interviews revealed that caregivers ... and just the nature of life," said lead ...
... a timely reminder of the issues surrounding the binge ... people and alcohol, a team lead by Professor Christine ... funded by the Economic and Social Research Council (ESRC) ... Focusing on the role of marketing practices in shaping ...
... Team Sponsored by Land Rover, St. Regis Resort Aspen, National ... Land Rover America,s Polo Cup Team participated in the prestigious ... weekend filled with world class polo and camaraderie on and ... was comprised of John Gobin at 8 goals, (one of ...
... against troublesome complication, study finds , , FRIDAY, Dec. 26 ... before cardiac surgery may lower their chances of having ... on variables such as age and the complexity of ... this condition of confusion following heart surgery. The condition ...
Other Medicine News:Health News:Prime Companies Announces Launch of New Dental Web Site 2Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 2Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 3Health News:Max Muscle Sports Nutrition Offers $25,000 Reward For Your New Years Resolution 4Health News:Family members of critically ill patients want to discuss loved ones' uncertain prognoses 2Health News:T'is the season to be jolly? 2Health News:Land Rover America's Polo Cup Team Plays in USPA World Snow Polo Championships, Aspen, Colorado 2Health News:Land Rover America's Polo Cup Team Plays in USPA World Snow Polo Championships, Aspen, Colorado 3
(Date:12/16/2009)... MAQUET Cardiovascular LLC, a leading ... it has signed a three-year single source ... supply contracting company, for MAQUET,s market-leading VASOVIEW ... products assist healthcare providers in obtaining veins ... only small incisions. This allows for faster ...
(Date:12/16/2009)... Dec. 16 Naurex Inc., a new ... and other CNS disorders based on its novel ... presented at a major medical meeting showed that ... anxiolytic-like activity with no signs of the CNS-related ... NMDA receptor(1). The studies also showed that ...
(Date:12/16/2009)... NEW YORK, Dec. 16 Keryx ... today the initiation of a Phase 3 ... Company,s PI3K/Akt pathway inhibitor, in relapsed / ... entitled, "A Phase 3 Randomized Study to ... Added to the Combination of Bortezomib (Velcade®) ...
Breaking Medicine Technology:MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 2Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 3Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 4Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 5Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 6Keryx Biopharmaceuticals, Inc. Initiates Phase 3 Registration Trial of KRX-0401 (Perifosine) for Treatment of Patients with Advanced Multiple Myeloma 7New Directions in Angioedema 3A A Focus on Etiologies and Clinical Approach 48496 1New Directions in Angioedema 3A A Focus on Etiologies and Clinical Approach 48496 2Parents key in new measure to evaluate language in children with autism 48494 1Parents key in new measure to evaluate language in children with autism 48494 2Parents key in new measure to evaluate language in children with autism 48494 3Pre pregnancy depressed mood may heighten risk for premature birth 8792 1Pre pregnancy depressed mood may heighten risk for premature birth 8792 2Pre pregnancy depressed mood may heighten risk for premature birth 8792 3